Trasylol Cases Should Remain in State Court, 7th Circuit Affirms

CHICAGO - Four identical Trasylol injury cases cannot be removed to federal court pursuant to the Class Action Fairness Act because they do not have at least 100 plaintiffs, a federal appeals court has affirmed. Anderson, et al. v. Bayer Corp., Nos. 10-8003, 10-8004, 10-8005, 10-8006 (7th Cir.).

On June 22, the 7th Circuit U.S. Court of Appeals further ruled that it does not have jurisdiction over the issue of fraudulent joinder.

In five separate, virtually identical complaints filed in the St. Clair County (Ill.) Circuit Court, plaintiffs sued Bayer for personal injuries allegedly caused by Trasylol. Bayer removed …